- Division of Translational and Clinical Sciences – DTCS
- Oncology 2 – Translational Clinical – OTC
- Study Section:
- Mechanisms of Cancer Therapeutics - 1 Study Section – MCT1
Dr. Lambratu Rahman Sesay serves as the Scientific Review Officer for the Basic Mechanism of Cancer Therapeutics Study Section within the Oncology Translational Clinical (OTC) Integrated Review Group. Dr. Rahman Sesay received her Ph.D. in biochemistry from Howard University in Washington, DC. Before coming to CSR, she was an intramural research training associate in the Molecular Therapeutics Program at the National Cancer Institute.